| scholarly article | Q13442814 |
| P2093 | author name string | Chan Young Shin | |
| Hee Jin Kim | |||
| Pitna Kim | |||
| P2860 | cites work | Sanchi for acute ischaemic stroke | Q24240964 |
| Potential effects of microglial activation induced by ginsenoside Rg3 in rat primary culture: enhancement of type A Macrophage Scavenger Receptor expression | Q28570656 | ||
| Animal models of anxiety disorders in rats and mice: some conceptual issues | Q30471279 | ||
| Neuroprotective effects of water extracts of American Ginseng on SH-SY5Y cells apoptosis induced by Abeta25-35 | Q33404179 | ||
| Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation | Q33747205 | ||
| Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury | Q34014207 | ||
| Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng | Q34195369 | ||
| Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice | Q34246976 | ||
| Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study | Q34465497 | ||
| Effect of combination therapy with sodium ozagrel and panax ginseng on transient cerebral ischemia model in rats | Q34497129 | ||
| Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins | Q34546193 | ||
| Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat. | Q34768799 | ||
| Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy | Q35203734 | ||
| Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis | Q35544526 | ||
| The Protective Effect of Black Ginseng Against Transient Focal Ischemia-induced Neuronal Damage in Rats | Q35764831 | ||
| Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model | Q35831048 | ||
| Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action | Q36016935 | ||
| Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus | Q36110594 | ||
| Use of ginseng in medicine with emphasis on neurodegenerative disorders | Q36414406 | ||
| Malonylginsenoside Rb1 potentiates nerve growth factor (NGF)-induced neurite outgrowth of cultured chick embryonic dorsal root ganglia | Q36738165 | ||
| Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. | Q46914460 | ||
| Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway | Q46944133 | ||
| Ginseng total saponins enhance neurogenesis after focal cerebral ischemia | Q47344264 | ||
| Inactivation of GABAA receptor reduces ginsenoside Rb3 neuroprotection in mouse hippocampal slices after oxygen–glucose deprivation | Q47350090 | ||
| Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo | Q47351695 | ||
| Anxiolytic effect of saponins from Panax quinquefolium in mice | Q47810364 | ||
| Proliferative effect of ginseng saponin on neurite extension of primary cultured neurons of the rat cerebral cortex | Q48113770 | ||
| Intravenous infusion of dihydroginsenoside Rb1 prevents compressive spinal cord injury and ischemic brain damage through upregulation of VEGF and Bcl-XL. | Q48121913 | ||
| Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity | Q48360337 | ||
| Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration | Q48405145 | ||
| Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings | Q48465199 | ||
| Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway | Q48473872 | ||
| Anticonvulsant and neuroprotective effects of ginsenosides in rats | Q48493917 | ||
| Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women | Q48564196 | ||
| Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides | Q48569576 | ||
| Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root. | Q48669338 | ||
| Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. | Q48672915 | ||
| Anxiolytic activity of Panax ginseng roots: an experimental study | Q48684797 | ||
| Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia | Q48720477 | ||
| Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes | Q48732654 | ||
| Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice | Q48740906 | ||
| Prevention of ischemic neuronal death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression | Q48767871 | ||
| Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia | Q48774295 | ||
| Extracts of Ginkgo biloba and Panax ginseng protect brain proteins from free radical induced oxidative damage in vitro | Q48808491 | ||
| Preventive action of Panax ginseng roots in hypercortisolism-induced Impairment of hippocampal neurons in male C57BL/6N mice | Q48821671 | ||
| Cerebroprotective effect of Korean ginseng tea against global and focal models of ischemia in rats. | Q48842405 | ||
| Antidepressant-like effect of altered Korean red ginseng in mice | Q48853965 | ||
| Preliminary study on antiamnestic mechanism of ginsenoside Rg1 and Rb1. | Q48869193 | ||
| Metabolic regulation of brain Abeta by neprilysin | Q48869458 | ||
| Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vivo | Q48873437 | ||
| Ginsenoside Rp1, a Ginsenoside Derivative, Blocks Promoter Activation of iNOS and COX-2 Genes by Suppression of an IKKβ-mediated NF-кB Pathway in HEK293 Cells | Q36860863 | ||
| Inhibition of TNF-α-mediated NF-κB Transcriptional Activity in HepG2 Cells by Dammarane-type Saponins from Panax ginseng Leaves | Q36861113 | ||
| Ginsenosides: are any of them candidates for drugs acting on the central nervous system? | Q37031566 | ||
| Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients | Q37301903 | ||
| Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng. | Q37354222 | ||
| Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway. | Q37395900 | ||
| Ginsenosides protect striatal neurons in a cellular model of Huntington's disease | Q37473242 | ||
| Ginsenoside Rg3 enhances large conductance Ca2+-activated potassium channel currents: a role of Tyr360 residue | Q37599395 | ||
| Genetic animal models of Parkinson's disease | Q37765030 | ||
| Ginsenosides and their CNS targets. | Q37818509 | ||
| Overview of animal models of attention deficit hyperactivity disorder (ADHD). | Q37826157 | ||
| Are herbal compounds the next frontier for alleviating learning and memory impairments? An integrative look at memory, dementia and the promising therapeutics of traditional chinese medicines | Q37838363 | ||
| Panax ginseng increases hypoxia-induced down-regulated cellular response related genes in human neuroblastoma cells, SK-N-MC. | Q38303715 | ||
| Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells | Q39013296 | ||
| Chronic oral administration of ginseng extract results in behavioral change but has no effects in mice models of affective and anxiety disorders. | Q39271231 | ||
| Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice. | Q39284050 | ||
| Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt | Q39426394 | ||
| Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells | Q39429018 | ||
| Administration of BDNF/ginsenosides combination enhanced synaptic development in human neural stem cells | Q39629266 | ||
| Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. | Q39641054 | ||
| Rg1 protects iron‐induced neurotoxicity through antioxidant and iron regulatory proteins in 6‐OHDA‐treated MES23.5 cells | Q39651300 | ||
| Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice | Q39673251 | ||
| Ginsenosides inhibit NMDA receptor-mediated epileptic discharges in cultured hippocampal neurons | Q39687636 | ||
| Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways | Q39792163 | ||
| Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake | Q39801115 | ||
| The neuroprotective effects of ginsenosides on calcineurin activity and tau phosphorylation in SY5Y cells | Q39839489 | ||
| Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways | Q39846076 | ||
| Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin | Q39882978 | ||
| Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes | Q40006918 | ||
| Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells | Q40284018 | ||
| Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro | Q40343680 | ||
| Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice | Q40737551 | ||
| Neurotrophic and neuroprotective actions of ginsenosides Rb(1) and Rg(1). | Q40785369 | ||
| Voltage-dependent inhibition of brain Na(+) channels by American ginseng | Q40827883 | ||
| Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice | Q42168838 | ||
| Up-regulation of M1 muscarinic receptors expressed in CHOm1 cells by panaxynol via cAMP pathway | Q42479344 | ||
| Anxiolytic-like effects of ginsenosides on the elevated plus-maze model in mice | Q42666840 | ||
| First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder | Q42720332 | ||
| Panax ginseng may improve some symptoms of attention-deficit hyperactivity disorder | Q42720342 | ||
| Ginsenoside Rb1 protects PC12 cells against β-amyloid-induced cell injury | Q42743803 | ||
| Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro | Q48881218 | ||
| Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors | Q48888108 | ||
| Effects of Panax notoginseng saponins on proliferation and differentiation of rat hippocampal neural stem cells | Q48908673 | ||
| Panax Notoginseng Burk attenuates impairment of learning and memory functions and increases ED1, BDNF and beta-secretase immunoreactive cells in chronic stage ischemia-reperfusion injured rats | Q48961615 | ||
| Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice. | Q48969931 | ||
| Intranasal ginsenoside Rb1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats | Q48974202 | ||
| Wild ginseng attenuates repeated morphine-induced behavioral sensitization in rats | Q48987632 | ||
| Ginseng pretreatment protects against transient global cerebral ischemia in the rat: measurement of local cerebral glucose utilization by [14C]deoxyglucose autoradiography | Q49015187 | ||
| Anti-lipid peroxidation and protection of ginsenosides against cerebral ischemia-reperfusion injuries in rats | Q49079054 | ||
| Panax quinquefolium saponins reduce myocardial hypoxia-reoxygenation injury by inhibiting excessive endoplasmic reticulum stress | Q50265910 | ||
| Therapeutic effect of Korean red ginseng on inflammatory cytokines in rats with focal cerebral ischemia/reperfusion injury. | Q50549346 | ||
| Wild ginseng attenuates anxiety- and depression-like behaviors during morphine withdrawal. | Q50604021 | ||
| An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. | Q50639189 | ||
| Ginsenoside Rb(1) prevents image navigation disability, cortical infarction, and thalamic degeneration in rats with focal cerebral ischemia. | Q50675459 | ||
| HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: a double-blind, placebo-controlled study. | Q50774349 | ||
| Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats. | Q50790755 | ||
| Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation. | Q51028436 | ||
| Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. | Q51034620 | ||
| Panax ginseng enhances cognitive performance in Alzheimer disease. | Q51889237 | ||
| Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischemia. | Q52203749 | ||
| Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. | Q53384343 | ||
| [Effects of Shenfu injection on hypoxic-ischemic brain damage: experiment with neonatal rats]. | Q53572273 | ||
| Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats | Q71339192 | ||
| Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats | Q73146373 | ||
| Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway | Q73959115 | ||
| Effects of ginseng saponins on responses induced by various receptor stimuli | Q77329265 | ||
| Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia | Q79717598 | ||
| [Study on therapeutic window of opportunity for Panax notoginseng saponins following focal cerebral ischemia/reperfusion injury in rats] | Q80164702 | ||
| [Effect of Panax notoginseng saponins on intercellular adhesion molecule-1 expression and neutrophil infiltration in cerebral infarction tissue of rats] | Q81136614 | ||
| Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study | Q82537140 | ||
| Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats | Q83032701 | ||
| Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia | Q83160278 | ||
| Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice | Q84335570 | ||
| Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis | Q84520144 | ||
| [Effects of ginsenosides on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor in rats exposed to chronic unpredictable mild stress] | Q84753984 | ||
| Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease | Q42744653 | ||
| 20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests | Q42963845 | ||
| Compound K, a metabolite of ginsenosides, facilitates spontaneous GABA release onto CA3 pyramidal neurons | Q43044139 | ||
| Effects of ginseng saponin on acute cocaine-induced alterations in evoked dopamine release and uptake in rat brain nucleus accumbens | Q43146887 | ||
| Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells | Q43150404 | ||
| A flavonol glycoside, isolated from roots of Panax notoginseng, reduces amyloid-beta-induced neurotoxicity in cultured neurons: signaling transduction and drug development for Alzheimer's disease. | Q43161344 | ||
| Panaxatriol saponins extracted from Panax notoginseng induces thioredoxin-1 and prevents 1-methyl-4-phenylpyridinium ion-induced neurotoxicity | Q43254755 | ||
| Effect of ginseng saponins on beta-amyloid-suppressed acetylcholine release from rat hippocampal slices. | Q43753818 | ||
| Antiepileptic activity of Panax ginseng against pentylenetetrazole induced kindling in rats. | Q43908606 | ||
| The nootropic properties of ginseng saponin Rb1 are linked to effects on anxiety | Q44218838 | ||
| Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells | Q44260601 | ||
| Effect of ginsenoside Rb1 on long-term potentiation in the dentate gyrus of anaesthetized rats | Q44330765 | ||
| Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets | Q44478325 | ||
| Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress | Q44523563 | ||
| Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease | Q44668541 | ||
| Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells | Q44721390 | ||
| Ginsenoside Rh2 reduces ischemic brain injury in rats | Q44782516 | ||
| An antidepressant effect of Sho-ju-sen, a Japanese herbal medicine, assessed by learned helplessness model in mice | Q44800219 | ||
| Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress | Q45230170 | ||
| Anticonvulsant activity of ginseng on seizures induced by chemical convulsants | Q45231301 | ||
| Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides | Q45239602 | ||
| Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. | Q45919922 | ||
| Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. | Q46008943 | ||
| Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress. | Q46017498 | ||
| Panax notoginseng Attenuates the Infarct Volume in Rat Ischemic Brain and the Inflammatory Response of Microglia | Q46079113 | ||
| Panax ginseng protects against global ischemia injury in rat hippocampus | Q46082935 | ||
| Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model | Q46097963 | ||
| Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus | Q46169706 | ||
| Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion | Q46212321 | ||
| 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain | Q46251145 | ||
| Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins | Q46253572 | ||
| Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction | Q46446234 | ||
| Effects of Ginsenoside Rbi on Central Cholinergic Metabolism | Q46514127 | ||
| Inhibitory effects of ginseng total saponins on behavioral sensitization and dopamine release induced by cocaine | Q46725454 | ||
| Ginsenoside Rg1 restores the impairment of learning induced by chronic morphine administration in rats | Q46727028 | ||
| Effect of ginseng saponins on enhanced dopaminergic transmission and locomotor hyperactivity induced by nicotine | Q46776466 | ||
| Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia | Q46847767 | ||
| P433 | issue | 1 | |
| P921 | main subject | nervous system | Q9404 |
| ginseng | Q20817212 | ||
| P304 | page(s) | 8-29 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Journal of Ginseng Research | Q26841821 |
| P1476 | title | A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system | |
| P478 | volume | 37 |
| Q37721402 | A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease |
| Q36437878 | A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease |
| Q38960814 | A dual purpose cell line of an Indian congener of ginseng--Panax sikkimensis with distinct ginsenoside and anthocyanin production profiles |
| Q39243823 | A literature update elucidating production of Panax ginsenosides with a special focus on strategies enriching the anti-neoplastic minor ginsenosides in ginseng preparations |
| Q57493673 | Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study |
| Q47619319 | Acupuncture plus Herbal Medicine for Alzheimer's Disease: A Systematic Review and Meta-Analysis |
| Q34719242 | American ginseng attenuates azoxymethane/dextran sodium sulfate-induced colon carcinogenesis in mice |
| Q41577043 | Anti-inflammatory activity of AP-SF, a ginsenoside-enriched fraction, from Korean ginseng |
| Q27027482 | Antioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migration |
| Q92043335 | Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects |
| Q38532717 | Brain Food for Alzheimer-Free Ageing: Focus on Herbal Medicines |
| Q89719727 | Characterization and Antioxidant Activity Determination of Neutral and Acidic Polysaccharides from Panax Ginseng C. A. Meyer |
| Q38737979 | Component analysis and target cell-based neuroactivity screening of Panax ginseng by ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry |
| Q38995805 | Compound K derived from ginseng: neuroprotection and cognitive improvement |
| Q34652532 | Dietary supplementation of chinese ginseng prevents obesity and metabolic syndrome in high-fat diet-fed mice |
| Q92776035 | Effect of Omega-3 and Korean Red Ginseng on Children with Attention Deficit Hyperactivity Disorder: An Open-Label Pilot Study |
| Q41567638 | Effect of single-dose Ginkgo biloba and Panax ginseng on driving performance |
| Q92308031 | Effects of Ginsenoside Rg1 Regulating Wnt/β-Catenin Signaling on Neural Stem Cells to Delay Brain Senescence |
| Q57212660 | Effects of Panax ginseng C.A. Meyer extract on the offspring of adult mice with maternal immune activation |
| Q33702630 | Effects of medicinal plants on Alzheimer's disease and memory deficits. |
| Q57222931 | Evaluation of four different analytical tools to determine the regional origin of Gastrodia elata and Rehmannia glutinosa on the basis of metabolomics study |
| Q36656651 | GABA-BZD Receptor Modulating Mechanism of Panax quinquefolius against 72-h Sleep Deprivation Induced Anxiety like Behavior: Possible Roles of Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation |
| Q42368213 | Ginseng Extract G115 Attenuates Ethanol-Induced Depression in Mice by Increasing Brain BDNF Levels |
| Q35675132 | Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats |
| Q27007545 | Ginseng: a promising neuroprotective strategy in stroke |
| Q90394628 | Ginsenoside Compound K Regulates Amyloid β via the Nrf2/Keap1 Signaling Pathway in Mice with Scopolamine Hydrobromide-Induced Memory Impairments |
| Q36941956 | Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. |
| Q87506431 | Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury |
| Q47615223 | Ginsenoside Rb1 rescues anxiety-like responses in a rat model of post-traumatic stress disorder |
| Q37731942 | Ginsenoside Rd as a potential neuroprotective agent prevents trimethyltin injury |
| Q92178058 | Ginsenoside Re Inhibits ROS/ASK-1 Dependent Mitochondrial Apoptosis Pathway and Activation of Nrf2-Antioxidant Response in Beta-Amyloid-Challenged SH-SY5Y Cells |
| Q93042742 | Ginsenoside Rf inhibits cyclooxygenase-2 induction via peroxisome proliferator-activated receptor gamma in A549 cells |
| Q35080838 | Ginsenoside Rg-1 protects retinal pigment epithelium (RPE) cells from cobalt chloride (CoCl2) and hypoxia assaults |
| Q47133791 | Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease |
| Q55464472 | Ginsenoside Rg1 modulates medial prefrontal cortical firing and suppresses the hippocampo-medial prefrontal cortical long-term potentiation. |
| Q48058624 | Ginsenoside Rg1 reverses stress-induced depression-like behaviours and brain-derived neurotrophic factor expression within the prefrontal cortex |
| Q46183213 | Ginsenoside Rk1 bioactivity: a systematic review. |
| Q37706092 | Ginsenosides Rb1 and Rg1 Stimulate Melanogenesis in Human Epidermal Melanocytes via PKA/CREB/MITF Signaling |
| Q91906850 | Ginsenosides: the need to move forward from bench to clinical trials |
| Q89920317 | Gintonin-Enriched Fraction Suppresses Heat Stress-Induced Inflammation Through LPA Receptor |
| Q90400196 | Herbal Compatibility of Ginseng and Rhubarb Exerts Synergistic Neuroprotection in Cerebral Ischemia/Reperfusion Injury of Rats |
| Q91906950 | Impact of NR1I2, adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers |
| Q48315917 | Inhibition of Autophagy is Involved in the Protective Effects of Ginsenoside Rb1 on Spinal Cord Injury. |
| Q33849937 | Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma |
| Q92155677 | Integrated Metabolomics and Network Pharmacology Study on Immunoregulation Mechanisms of Panax ginseng through Macrophages |
| Q64075631 | Jia-Wei-Kai-Xin-San, an Herbal Medicine Formula, Ameliorates Cognitive Deficits via Modulating Metabolism of Beta Amyloid Protein and Neurotrophic Factors in Hippocampus of Aβ Induced Cognitive Deficit Mice |
| Q55096237 | Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2. |
| Q48244833 | Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells |
| Q58595438 | Korean Red Ginseng mitigates spinal demyelination in a model of acute multiple sclerosis by downregulating p38 mitogen-activated protein kinase and nuclear factor-κB signaling pathways |
| Q37690692 | Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease. |
| Q92588815 | Neuroprotective Effects of Red Ginseng Saponins in Scopolamine-Treated Rats and Activity Screening Based on Pharmacokinetics |
| Q39013824 | Pharmacokinetic Drug Interactions with Panax ginseng |
| Q39009840 | Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review |
| Q26795546 | Plant-derived neuroprotective agents in Parkinson's disease |
| Q37544141 | Pretreatment with Ginseng Fruit Saponins Affects Serotonin Expression in an Experimental Comorbidity Model of Myocardial Infarction and Depression |
| Q86446427 | Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathway |
| Q33634930 | Quantitative Analysis of Panax ginseng by FT-NIR Spectroscopy |
| Q35675142 | Review of cases of patient risk associated with ginseng abuse and misuse |
| Q36534179 | Supplementation of Korean Red Ginseng improves behavior deviations in animal models of autism |
| Q92753246 | Supplementation of Plants with Immunomodulatory Properties during Pregnancy and Lactation-Maternal and Offspring Health Effects |
| Q91834195 | Synergistic effect of Korean red ginseng and Pueraria montana var. lobata against trimethyltin-induced cognitive impairment |
| Q38638532 | TCM, brain function and drug space |
| Q93160052 | The Chinese Herbal Formula PAPZ Ameliorates Behavioral Abnormalities in Depressive Mice |
| Q35438167 | The dietary flavonoid Kaempferol mediates anti-inflammatory responses via the Src, Syk, IRAK1, and IRAK4 molecular targets |
| Q37744368 | The psychopharmacological activities of Vietnamese ginseng in mice: characterization of its psychomotor, sedative-hypnotic, antistress, anxiolytic, and cognitive effects |
| Q64052258 | Transcriptomic profiling reveals MEP pathway contributing to ginsenoside biosynthesis in Panax ginseng |
| Q58595460 | ginseng as an adjuvant treatment for Alzheimer's disease |
Search more.